Alpha Cognition Targets 2,000 ZUNVEYL Prescribers In 2026; Plans 3 Long-Term Care Alzheimer's Studies; Anticipates $3M Asia Licensing Milestone; Aims For Operating Profitability In 2027
ZUNVEYL prescriber base expected to expand to approximately 2,000 prescribing healthcare providers, and an increase in nursing home penetrationCompany expects to complete and/or initiate three studies in 2026 supporting
